Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 11351-11400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06706544
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
PHASE2/PHASE3
Recruiting
42 participants
Started: Feb 7, 2025 · Completed: Mar 31, 2030
4 conditions
8 sponsors
1 location
NCT06717373
Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis
NA
Recruiting
200 participants
Started: Feb 7, 2025 · Completed: Apr 1, 2025
1 condition
1 sponsor
1 location
NCT06802952
RTMS for CHR Based on Personalized Targets Using Magnetoencephalography
NA
Recruiting
26 participants
Started: Feb 7, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06773091
A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors
PHASE1
Recruiting
76 participants
Started: Feb 7, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06779552
CardioMEMS HF System Coverage with Evidence Development Study
N/A
Recruiting
1,000 participants
Started: Feb 7, 2025 · Completed: Mar 31, 2032
1 condition
1 sponsor
1 location
NCT06766825
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)
PHASE2
Recruiting
90 participants
Started: Feb 7, 2025 · Completed: Jun 1, 2026
5 conditions
3 sponsors
1 location
NCT06817122
"The Let's Talk Tech Tool to Support Decision Making About Technology Use"
NA
Recruiting
240 participants
Started: Feb 7, 2025 · Completed: Apr 30, 2026
2 conditions
2 sponsors
1 location
NCT06531018
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
PHASE1/PHASE2
Recruiting
100 participants
Started: Feb 7, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06785636
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
PHASE1/PHASE2
Recruiting
252 participants
Started: Feb 7, 2025 · Completed: Apr 30, 2029
10 conditions
2 sponsors
8 locations
NCT06778187
Oral-ATO for TP53-mutated Myeloid Malignancies
PHASE2
Recruiting
30 participants
Started: Feb 7, 2025 · Completed: Feb 29, 2028
5 conditions
1 sponsor
1 location
NCT07190443
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
PHASE3
Recruiting
290 participants
Started: Feb 7, 2025 · Completed: Feb 6, 2035
4 conditions
2 sponsors
1 location
NCT06815718
Observational Study Evaluating the viQtor for Early Detection of Clinical Deterioration in Post-ICU Patients on General Wards
N/A
Recruiting
180 participants
Started: Feb 7, 2025 · Completed: Dec 30, 2025
5 conditions
1 sponsor
1 location
NCT06799351
Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
PHASE2/PHASE3
Recruiting
42 participants
Started: Feb 7, 2025 · Completed: Mar 31, 2030
4 conditions
6 sponsors
1 location
NCT07117890
Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations
PHASE2
Recruiting
14 participants
Started: Feb 7, 2025 · Completed: May 30, 2027
1 condition
1 sponsor
1 location
NCT06744920
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
PHASE3
Recruiting
180 participants
Started: Feb 7, 2025 · Completed: Feb 26, 2033
1 condition
1 sponsor
64 locations
NCT06798402
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
PHASE2
Recruiting
80 participants
Started: Feb 7, 2025 · Completed: Nov 1, 2025
1 condition
2 sponsors
1 location
NCT06886126
Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
PHASE2
Recruiting
240 participants
Started: Feb 7, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06732648
The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction
PHASE2/PHASE3
Recruiting
725 participants
Started: Feb 7, 2025 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06738173
Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer (GUILTI)
N/A
Recruiting
1,202 participants
Started: Feb 7, 2025 · Completed: Sep 30, 2029
1 condition
1 sponsor
1 location
NCT07174206
FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection
NA
Recruiting
520 participants
Started: Feb 7, 2025 · Completed: Feb 28, 2026
3 conditions
2 sponsors
1 location
NCT06679530
Music During Allogeneic Stem Cell Transplant Hospitalization
NA
Recruiting
35 participants
Started: Feb 7, 2025 · Completed: Dec 25, 2027
1 condition
1 sponsor
1 location
NCT06812078
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
PHASE2
Recruiting
40 participants
Started: Feb 7, 2025 · Completed: Feb 19, 2026
1 condition
1 sponsor
29 locations
NCT06537258
Heart Rate Variability and Inflammatory Bowel Disease
NA
Recruiting
128 participants
Started: Feb 6, 2025 · Completed: Oct 31, 2028
1 condition
2 sponsors
3 locations
NCT06796725
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
NA
Recruiting
60 participants
Started: Feb 6, 2025 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT06632977
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
PHASE2
Recruiting
474 participants
Started: Feb 6, 2025 · Completed: Oct 11, 2034
2 conditions
2 sponsors
70 locations
NCT06784960
Communication Strategies to Increase HPV Vaccination Intention
NA
Recruiting
3,689 participants
Started: Feb 6, 2025 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT06630845
Comparison of Whole Body DWI to FDG PET
NA
Recruiting
30 participants
Started: Feb 6, 2025 · Completed: Oct 31, 2029
1 condition
3 sponsors
1 location
NCT07161245
RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis
NA
Recruiting
64 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06483555
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
PHASE1/PHASE2
Recruiting
104 participants
Started: Feb 6, 2025 · Completed: Aug 31, 2027
3 conditions
1 sponsor
1 location
NCT06799715
Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose
NA
Recruiting
20 participants
Started: Feb 6, 2025 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT06831838
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
NA
Recruiting
100 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06843616
A PILOT TRIAL of a DISPOSABLE INTRACEREBRAL ASPIRATION ENDOSCOPE for the TREATMENT of INTRACEREBRAL HEMATOMA(FAST-HET)
NA
Recruiting
16 participants
Started: Feb 6, 2025 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06793371
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
PHASE2
Recruiting
60 participants
Started: Feb 6, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
20 locations
NCT06811714
Comparison of Oxidants and Antioxidants in Breastmilk Under Different Anesthesia Protocols
N/A
Recruiting
141 participants
Started: Feb 6, 2025 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06678074
Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI
PHASE1/PHASE2
Recruiting
10 participants
Started: Feb 6, 2025 · Completed: Sep 1, 2026
4 conditions
3 sponsors
2 locations
NCT06765161
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
PHASE3
Recruiting
30 participants
Started: Feb 6, 2025 · Completed: Jan 6, 2027
1 condition
2 sponsors
1 location
NCT06683391
Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes
NA
Recruiting
32 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT06319430
Technology in Play for Children With Physical Disabilities: the Dice Model of Play
NA
Recruiting
20 participants
Started: Feb 6, 2025 · Completed: May 28, 2026
2 conditions
2 sponsors
1 location
NCT06793527
Comparison of the Efficacy of Celiac Plexus Blockade, ESP and Lidocaine Infusion Under OFA
NA
Recruiting
300 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06481319
Implementing a Pilot Patient Navigator Program to Improve Access to Infertility Care for Underserved Patients
NA
Recruiting
40 participants
Started: Feb 6, 2025 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06540651
Efficacy of Light Therapy in Treatment of Chronic Cluster Headache
NA
Recruiting
48 participants
Started: Feb 6, 2025 · Completed: May 5, 2027
1 condition
1 sponsor
2 locations
NCT05990465
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
PHASE1
Recruiting
12 participants
Started: Feb 6, 2025 · Completed: Jul 31, 2027
6 conditions
1 sponsor
1 location
NCT06804668
Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease
NA
Recruiting
6 participants
Started: Feb 6, 2025 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT06374147
"Prapela® SVS Incubator Pad for Apnea of Prematurity"
NA
Recruiting
140 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT06786832
Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care
NA
Recruiting
500 participants
Started: Feb 6, 2025 · Completed: Jan 31, 2033
5 conditions
2 sponsors
1 location
NCT06423664
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
NA
Recruiting
20 participants
Started: Feb 6, 2025 · Completed: Aug 31, 2026
1 condition
5 sponsors
3 locations
NCT06816381
Quantifying Uterine Elastography in Menstruating Women
N/A
Recruiting
40 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06818409
Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergoing Hip Fracture Surgery
N/A
Recruiting
100 participants
Started: Feb 6, 2025 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT06777368
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
N/A
Recruiting
225 participants
Started: Feb 6, 2025 · Completed: Jul 31, 2033
1 condition
1 sponsor
56 locations
NCT06754852
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
PHASE1/PHASE2
Recruiting
108 participants
Started: Feb 6, 2025 · Completed: Jul 31, 2027
2 conditions
1 sponsor
1 location
Previous
1
More pages
225
226
227
228
229
230
231
More pages
1333
Next